Legochem Biosciences Stock Cash And Equivalents
| 141080 Stock | KRW 68,000 100.00 0.15% |
LegoChem Biosciences fundamentals help investors to digest information that contributes to LegoChem Biosciences' financial success or failures. It also enables traders to predict the movement of LegoChem Stock. The fundamental analysis module provides a way to measure LegoChem Biosciences' intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to LegoChem Biosciences stock.
LegoChem |
LegoChem Biosciences Company Cash And Equivalents Analysis
LegoChem Biosciences' Cash or Cash Equivalents are the most liquid of all assets found on the company's balance sheet. It is used in calculating many of the firm's liquidity ratios and is a good indicator of the overall financial health of a company. Companies with a lot of cash are usually attractive takeover targets. Cash Equivalents are balance sheet items that are typically reported using currency printed on notes.
Current LegoChem Biosciences Cash And Equivalents | 29.39 B |
Most of LegoChem Biosciences' fundamental indicators, such as Cash And Equivalents, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, LegoChem Biosciences is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Cash equivalents represent current assets that are easily convertible to cash such as short term bonds, savings account, money market funds, or certificate of deposits (CDs). One of the important consideration companies make when classifying assets as cash equivalent is that investments they report on their balance sheets under current assets should have almost no risk of change in value over the next few months (usually three months).
| Competition |
In accordance with the recently published financial statements, LegoChem Biosciences has 29.39 B in Cash And Equivalents. This is much higher than that of the Life Sciences Tools & Services sector and significantly higher than that of the Health Care industry. The cash and equivalents for all Republic of Korea stocks is notably lower than that of the firm.
LegoChem Cash And Equivalents Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses LegoChem Biosciences' direct or indirect competition against its Cash And Equivalents to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of LegoChem Biosciences could also be used in its relative valuation, which is a method of valuing LegoChem Biosciences by comparing valuation metrics of similar companies.LegoChem Biosciences is currently under evaluation in cash and equivalents category among related companies.
LegoChem Fundamentals
| Return On Equity | -2.16 | |||
| Return On Asset | 0.04 | |||
| Profit Margin | 0.24 % | |||
| Operating Margin | 0.15 % | |||
| Current Valuation | 1.09 T | |||
| Shares Outstanding | 10.6 M | |||
| Shares Owned By Insiders | 19.53 % | |||
| Shares Owned By Institutions | 8.26 % | |||
| Price To Sales | 9.51 X | |||
| Revenue | 32.16 B | |||
| Gross Profit | 34.81 B | |||
| EBITDA | 12.28 B | |||
| Net Income | (23.39 B) | |||
| Cash And Equivalents | 29.39 B | |||
| Total Debt | 9.41 B | |||
| Debt To Equity | 0.40 % | |||
| Current Ratio | 8.00 X | |||
| Cash Flow From Operations | (42.05 B) | |||
| Target Price | 50000.0 | |||
| Number Of Employees | 12 | |||
| Beta | 0.9 | |||
| Market Capitalization | 403.31 B | |||
| Total Asset | 293.23 B | |||
| Retained Earnings | (38.4 B) | |||
| Working Capital | 18.47 B | |||
| Current Asset | 29.6 B | |||
| Current Liabilities | 11.13 B | |||
| Z Score | 25.2 | |||
| Net Asset | 293.23 B |
About LegoChem Biosciences Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze LegoChem Biosciences's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of LegoChem Biosciences using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of LegoChem Biosciences based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Thematic Opportunities
Explore Investment Opportunities
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in LegoChem Biosciences. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in nation. Note that the LegoChem Biosciences information on this page should be used as a complementary analysis to other LegoChem Biosciences' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Center module to all portfolio management and optimization tools to improve performance of your portfolios.
Complementary Tools for LegoChem Stock analysis
When running LegoChem Biosciences' price analysis, check to measure LegoChem Biosciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy LegoChem Biosciences is operating at the current time. Most of LegoChem Biosciences' value examination focuses on studying past and present price action to predict the probability of LegoChem Biosciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move LegoChem Biosciences' price. Additionally, you may evaluate how the addition of LegoChem Biosciences to your portfolios can decrease your overall portfolio volatility.
| Content Syndication Quickly integrate customizable finance content to your own investment portal | |
| Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine |